Association between MYCN gene polymorphisms and neuroblastoma susceptibility: a case-control study in Chinese children from Jiangsu Province by Jiabin Liu, Mengzhen Zhang, Yu Ouyang, Jiaming Chang, Wenli Zhang, Chunlei Zhou, Jing He, Xinxin Zhang

Subjects: “…MYCN…”
Get full text

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy by Anders Valind, Bronte Manouk Verhoeven, Jens Enoksson, Jenny Karlsson, Gustav Christensson, Adriana Mañas, Kristina Aaltonen, Caroline Jansson, Daniel Bexell, Ninib Baryawno, David Gisselsson, Catharina Hagerling

Subjects: Get full text

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma by Seema Chugh, Jean C. Tien, Jennifer Hon, Carson Kenum, Rahul Mannan, Yunhui Cheng, Chi Chiang Li, Zainab I. Taher, Andrew D. Delekta, Pushpinder Singh Bawa, Ingrid J. Apel, Stephanie J. Miner, Xuhong Cao, Rohit Mehra, Saravana M. Dhanasekaran, Yuanyuan Qiao, Rajen Mody, Arul M. Chinnaiyan

Subjects: Get full text

Diminished MYCN Dosage Endows Cavitary Transformation in Retinoblastoma by Mingpeng Xu, MD, Hanhan Shi, MD, PhD, Yongning Shen, BS, Ludi Yang, MD, Yu Luan, MD, Xiang Gu, MD, Xuyang Wen, MD, PhD, Chuandi Zhou, MD, PhD, Renbing Jia, MD, PhD, Xunda Ji, MD, PhD, Peiquan Zhao, MD, PhD, Minglei Han, MD, PhD, Jiayan Fan, MD, PhD, Peiwei Chai, MD, PhD

Subjects: Get full text

Identification of Contactin-1 as a Potential Biomarker and Therapeutic Target in Neuroblastoma by Christa N. Grant, Carson A. Wills, Xiaoming Liu, Longgui Chen, Zhenqiu Liu, Hong-Gang Wang

Subjects: Get full text

ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis by Yunpeng Chen, Haixia Zhu, Yishu Luo, Tianyue Xie, Youyang Hu, Zhiwei Yan, Weichao Ji, YaXuan Wang, Qiyou Yin, Hua Xian

Subjects: Get full text

Corrigendum: Combination of rapamycin and MK-2206 induced cell death via autophagy and necroptosis in MYCN-amplified neuroblastoma cell lines by Yudi Dong, Yudi Dong, Wei Gong, Wei Gong, Zhongyan Hua, Zhongyan Hua, Bo Chen, Bo Chen, Guifeng Zhao, Guifeng Zhao, Zhihui Liu, Carol J. Thiele, Zhijie Li, Zhijie Li

Subjects: Get full text

PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status by Nadzifa Nugraheni, Ummi Maryam Zulfin, Beni Lestari, Novia Permata Hapsari, Muthi Ikawati, Rohmad Yudi Utomo, Yusuke Suenaga, Yoshitaka Hippo, Edy Meiyanto

Subjects: Get full text

Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable? by Wei Wang, Yi Du, Sayantap Datta, Josef F. Fowler, Hannah T. Sang, Najah Albadari, Wei Li, Jennifer Foster, Ruiwen Zhang

Subjects: Get full text

Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathway by Masahiro Hirayama, Eri Yamada, Hiromasa Aoki, Kazuya Izumi, Ayumi Amano, Kohki Toriuchi, Koichi Ogami, Mai Nagasaka, Yasumichi Inoue, Hidetoshi Hayashi, Satoru Takeshita, Hiroki Kakita, Yasumasa Yamada, Mineyoshi Aoyama

Subjects: Get full text

Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening by Lisa Götz, Jenny Wegert, Alireza Paikari, Silke Appenzeller, Sabrina Bausenwein, Christian Vokuhl, Taryn D. Treger, Jarno Drost, Christin Linderkamp, Dominik T. Schneider, Karen Ernestus, Steven W. Warman, Jörg Fuchs, Nils Welter, Norbert Graf, Sam Behjati, Rhoikos Furtwängler, Manfred Gessler

Subjects: Get full text

MYCN as an oncogene in pediatric brain tumors by Adriana Fernandez Garcia, Adriana Fernandez Garcia, Jayden Jackson, Jayden Jackson, Poorvi Iyer, Poorvi Iyer, Elissa G. Oliver, Elissa G. Oliver, Kosuke Funato, Kosuke Funato

Subjects: “…MYCN…”
Get full text

ZIP4 promotes glycolysis in cholangiocarcinoma cells by enhancing H3K4me3 modification and activating MYCN transcription by Jiwen WANG, Cheng ZHANG, Dexiang ZHANG, Xiaoling NI, Kun FAN, Houbao LIU

Subjects: Get full text

Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN by Yizhe Liu, Qili Shi, Yue Su, Zhiao Chen, Xianghuo He

Subjects: Get full text

Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH‐MYCN transgenic mice by Yen‐Tzu Liao, Zhi‐Kai Yu, Yi‐Xun Huang, Kuan‐Hung Lin, Ching‐Te Kuo, Tsai‐Shan Yang, Pei‐Yi Wu, Chi‐Tai Yeh, Yen‐Lin Liu, Chien‐Chin Chen, Chiung‐Nien Chen, Wen‐Ming Hsu, Hsinyu Lee

Subjects: Get full text

Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity by Nour A. Aljouda, Dewan Shrestha, Chelsea DeVaux, Rachelle R. Olsen, Satyanarayana Alleboina, Megan Walker, Yong Cheng, Kevin W. Freeman

Subjects: Get full text

Identification of Crucial Genes Associated With MYCN‐Driven Neuroblastoma Based on Single‐Cell Analysis and Machine Learning by Jiasi Zhang, Yichen Lei, Yaqin Wang, Wen Yu, Xiaoyan Zhao, Yongbing Zhu, Dedong Zhang, Siying Liu, Aiguo Liu

Subjects: “…MYCN amplification…”
Get full text

Transcriptional regulation of genes by MYCN in PAX3::FOXO1-positive rhabdomyosarcomas and their roles in cell cycle progression by Zoë S. Walters, Daniel Leongamornlert, Barbara Villarejo-Balcells, Carmen Tse, Reuben Pengelly, Ian Titley, Janet Shipley

Subjects: “…MYCN…”
Get full text

Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell Function by Cinthia N. Reed, Kaylee B. Garrison, Joshua Thammathong, Jindrich Cinatl, Martin Michaelis, Souvik Banerjee, April M. Weissmiller

Subjects: “…<i>MYCN</i>…”
Get full text

Neuroblastoma: morphological pattern, molecular genetic features, and prognostic factors by A. M. Stroganova, A. I. Karseladze

Subjects: Get full text